Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 12, 2026 00:25 UTC |
Giraudo BryanDirector
|
Exercise / conversionCommon Stock | 24,000 | $6.45 | $154,800.00 |
DisclosureSEC source: 0001104659-26-058860 · tm2614277-1_4seq1.xml · nonDerivative · entry 1 Giraudo Bryan · CIK 0001740847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects 10,000 shares of common stock that were previously held directly by the Reporting Person and which were transferred to the Bryan & Courtney Giraudo Trust. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 20:10 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-048572 · tm2612651-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,478 F1 · kind: This transaction involves a bona fide gift of securities from the Reporting Person to family and friends. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:58 UTC |
Ali AsifChief Financial Officer
|
SaleCommon Stock | 1,750 | $105.47 | $184,572.50 |
DisclosureSEC source: 0001104659-26-046110 · tm2612380-2_4seq1.xml · nonDerivative · entry 1 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,003 F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:33 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,265 | $0.00 Strike: $12.17 | $0.00 |
DisclosureSEC source: 0001104659-26-036317 · tm2610129-1_4seq1.xml · derivative · entry 5 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,282 Underlying: Common Stock · 5,265 shares Expires 2033-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option was granted to the Reporting Person on January 16, 2023 and vests in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:33 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001104659-26-036317 · tm2610129-1_4seq1.xml · derivative · entry 4 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,300 Underlying: Common Stock · 19,500 shares Expires 2032-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option was granted to the Reporting Person on April 18, 2022, one quarter vested on April 18, 2023 and the remaining three quarters vest in equal monthly installments through April 18, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:33 UTC |
Ali AsifChief Financial Officer
|
SaleCommon Stock | 24,765 | $104.24 | $2,581,503.60 |
DisclosureSEC source: 0001104659-26-036317 · tm2610129-1_4seq1.xml · nonDerivative · entry 3 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,753 F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $104.00 to $104.465. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:33 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionCommon Stock | 5,265 | $12.17 | $64,075.05 |
DisclosureSEC source: 0001104659-26-036317 · tm2610129-1_4seq1.xml · nonDerivative · entry 2 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:33 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionCommon Stock | 19,500 | $19.19 | $374,205.00 |
DisclosureSEC source: 0001104659-26-036317 · tm2610129-1_4seq1.xml · nonDerivative · entry 1 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes an aggregate of 433 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2026. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:36 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001104659-26-036319 · tm2610129-3_4seq1.xml · derivative · entry 3 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,971 Underlying: Common Stock · 15,000 shares Expires 2032-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option was granted to the Reporting Person on November 7, 2022, one quarter vested on November 7, 2023 and the remaining three quarters vest in equal monthly installments through November 7, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:36 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 15,000 | $104.79 | $1,571,850.00 |
DisclosureSEC source: 0001104659-26-036319 · tm2610129-3_4seq1.xml · nonDerivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,115 F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $103.99 to $105.54. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:36 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 15,000 | $8.04 | $120,600.00 |
DisclosureSEC source: 0001104659-26-036319 · tm2610129-3_4seq1.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:34 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $12.88 | $0.00 |
DisclosureSEC source: 0001104659-26-036318 · tm2610129-2_4seq1.xml · derivative · entry 3 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:34 UTC |
SELICK HAROLD EDirector
|
SaleCommon Stock | 24,000 | $105.00 | $2,520,000.00 |
DisclosureSEC source: 0001104659-26-036318 · tm2610129-2_4seq1.xml · nonDerivative · entry 2 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,845 Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:34 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionCommon Stock | 24,000 | $12.88 | $309,120.00 |
DisclosureSEC source: 0001104659-26-036318 · tm2610129-2_4seq1.xml · nonDerivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 54,641 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · derivative · entry 7 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,641 shares Expires 2028-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| March 25, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 54,641 | $101.00 | $5,518,741.00 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · nonDerivative · entry 5 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,938 Read SEC document |
| March 25, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 54,641 | $8.58 | $468,819.78 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · nonDerivative · entry 4 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 579,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 59 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · derivative · entry 6 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,641 Underlying: Common Stock · 59 shares Expires 2028-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 59 | $101.00 | $5,959.00 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · nonDerivative · entry 3 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,938 Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 59 | $8.58 | $506.22 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · nonDerivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 23:23 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-034736 · tm269861-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,938 F1 · kind: This transaction involves a bona fide gift of securities from the Reporting Person to relatives. F2 · balance_after: Includes an aggregate of 433 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2026. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 23:12 UTC |
Williams Lewis TDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $10.84 | $0.00 |
DisclosureSEC source: 0001104659-26-017176 · tm266755-1_4seq1.xml · derivative · entry 3 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 18,000 shares Expires 2027-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 23:12 UTC |
Williams Lewis TDirector
|
SaleCommon Stock | 18,000 | $82.42 | $1,483,560.00 |
DisclosureSEC source: 0001104659-26-017176 · tm266755-1_4seq1.xml · nonDerivative · entry 2 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,825 F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $81.47 to $83.12. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 23:12 UTC |
Williams Lewis TDirector
|
Exercise / conversionCommon Stock | 18,000 | $10.84 | $195,120.00 |
DisclosureSEC source: 0001104659-26-017176 · tm266755-1_4seq1.xml · nonDerivative · entry 1 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 21:38 UTC |
Waddill William D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.31 | $0.00 |
DisclosureSEC source: 0001104659-26-011575 · tm265544-1_4seq1.xml · derivative · entry 3 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2032-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 21:38 UTC |
Waddill William D.Director
|
SaleCommon Stock | 20,000 | $83.68 | $1,673,600.00 |
DisclosureSEC source: 0001104659-26-011575 · tm265544-1_4seq1.xml · nonDerivative · entry 2 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,825 F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $83.65 to $83.87. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 21:38 UTC |
Waddill William D.Director
|
Exercise / conversionCommon Stock | 20,000 | $8.31 | $166,200.00 |
DisclosureSEC source: 0001104659-26-011575 · tm265544-1_4seq1.xml · nonDerivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,068 | $0.00 Strike: $21.58 | $0.00 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · derivative · entry 13 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 4,068 shares Expires 2026-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These stock options are fully vested and will expire on October 11, 2026. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 4,068 | $83.19 | $338,416.92 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 9 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,505 F5 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $83.06 to $83.59. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 4,068 | $21.58 | $87,787.44 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 8 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:20 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.17 | $0.00 |
DisclosureSEC source: 0001104659-26-007128 · tm264253-2_4seq1.xml · derivative · entry 6 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,547 Underlying: Common Stock · 12,000 shares Expires 2033-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option was granted to the Reporting Person on January 16, 2023 and vests in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:20 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001104659-26-007128 · tm264253-2_4seq1.xml · derivative · entry 5 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,800 Underlying: Common Stock · 16,000 shares Expires 2032-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option was granted to the Reporting Person on April 18, 2022, one quarter vested on April 18, 2023 and the remaining three quarters vest in equal monthly installments through April 18, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:20 UTC |
Ali AsifChief Financial Officer
|
SaleCommon Stock | 18,203 | $83.14 | $1,513,397.42 |
DisclosureSEC source: 0001104659-26-007128 · tm264253-2_4seq1.xml · nonDerivative · entry 4 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,320 F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $82.80 to $83.595. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:20 UTC |
Ali AsifChief Financial Officer
|
SaleCommon Stock | 28,000 | $83.13 | $2,327,640.00 |
DisclosureSEC source: 0001104659-26-007128 · tm264253-2_4seq1.xml · nonDerivative · entry 3 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,523 F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $82.77 to $83.595. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:20 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionCommon Stock | 12,000 | $12.17 | $146,040.00 |
DisclosureSEC source: 0001104659-26-007128 · tm264253-2_4seq1.xml · nonDerivative · entry 2 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:20 UTC |
Ali AsifChief Financial Officer
|
Exercise / conversionCommon Stock | 16,000 | $19.19 | $307,040.00 |
DisclosureSEC source: 0001104659-26-007128 · tm264253-2_4seq1.xml · nonDerivative · entry 1 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes an aggregate of 446 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2025. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · derivative · entry 7 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,971 Underlying: Common Stock · 5,000 shares Expires 2032-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which vested on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 5,000 | $82.00 | $410,000.00 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · nonDerivative · entry 5 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,115 Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $8.04 | $40,200.00 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · nonDerivative · entry 4 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,205 | $0.00 Strike: $21.58 | $0.00 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · derivative · entry 12 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,068 Underlying: Common Stock · 14,205 shares Expires 2026-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These stock options are fully vested and will expire on October 11, 2026. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,685 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · derivative · entry 11 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,685 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These stock options are fully vested and will expire on April 29, 2026. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 14,205 | $84.05 | $1,193,930.25 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 7 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,505 F4 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84 to $84.075. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 14,205 | $21.58 | $306,543.90 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 6 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 588,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 10,685 | $84.00 | $897,540.00 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 5 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,505 F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84 to $84.095. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,685 | $4.21 | $44,983.85 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 4 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · derivative · entry 6 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,971 Underlying: Common Stock · 5,000 shares Expires 2032-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which vested on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 5,000 | $82.28 | $411,400.00 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · nonDerivative · entry 3 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,115 F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $82.14 to $82.55. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $8.04 | $40,200.00 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · nonDerivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,315 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · derivative · entry 10 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,685 Underlying: Common Stock · 19,315 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These stock options are fully vested and will expire on April 29, 2026. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 19,315 | $84.59 | $1,633,855.85 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 3 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,505 F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84.41 to $84.64. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.